ML239 10 mg | 99.54%
TargetMol
ML239 is a potent and selective inhibitor of breast cancer stem cells, with an IC50 of 1.16 μM.
More Information Supplier PageML239
Search Results
ML-18 1 mg | 100.00%
TargetMol
ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.
More Information Supplier PageML-18
ML-18 2 mg | 100.00%
TargetMol
ML-18 is a non-peptide bombesin receptor subtype-3 (BRS-3) antagonist with an IC50 of 4.8 μM.
More Information Supplier PageML-18
GSK461364 1 mg | 99.00%
TargetMol
GSK461364(Ki=2.2 nM) inhibits purified Plk1 .The specificity of GSK461364 for Plk1 is more than 1000-fold over Plk2/3.
More Information Supplier PageGSK461364
Ceftiofur hydrochloride 200 mg | 99.51%
TargetMol
Ceftiofur Hydrochloride is the hydrochloride salt form of ceftiofur, a semisynthetic, beta-lactamase-stable, broad-spectrum, third-generation cephalosporin with antibacterial activity.
More Information Supplier PageCeftiofur hydrochloride
Elesclomol 25 mg | 99.33%
TargetMol
Elesclomol (STA-4783) is an effective oxidative stress inducer that elicits pro-apoptosis of tumor cells.
More Information Supplier PageElesclomol
LDN-193189 HCl 25 mg | 100.00%
TargetMol
LDN193189 hydrochloride is a selective BMP type I receptor kinases inhibitor.
More Information Supplier PageLDN-193189 HCl
Entospletinib 2 mg | 99.05%
TargetMol
Entospletinib （IC50= 7.7 nM）is a specific Syk inhibitor, which is orally bioavailable.
More Information Supplier PageEntospletinib
Batimastat 25 mg | 98.55%
TargetMol
Batimastat (BB-94) is an effective, broad-spectrum matrix metalloprotease (MMP) inhibitor. Batimastat induces extracellular matrix degradation and inhibits angiogenesis, tumor growth and invasion, and metastasis.
More Information Supplier PageBatimastat
Methyl Isoferulate 5 mg | 99.50%
TargetMol
This product is isolated and purified from the leaves of Phyllostachys heterocycla
More Information Supplier PageMethyl Isoferulate
